Display options
Cite
Okyere P, Ephraim RKD, Okyere I, et al. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC Nephrol. 2021;22(1):156doi: 10.1186/s12882-021-02336-8.
Okyere, P., Ephraim, R. K. D., Okyere, I., Attakorah, J., Serwaa, D., Essuman, G., Abaka-Yawson, A., & Adoba, P. (2021). Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC nephrology, 22(1), 156. https://doi.org/10.1186/s12882-021-02336-8
Okyere, Perditer, et al. "Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana." BMC nephrology vol. 22,1 (2021): 156. doi: https://doi.org/10.1186/s12882-021-02336-8
Okyere P, Ephraim RKD, Okyere I, Attakorah J, Serwaa D, Essuman G, Abaka-Yawson A, Adoba P. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8. PMID: 33910506; PMCID: PMC8080413.
Copy Download .nbib Format: NLM
Share it on

BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8.

Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.

BMC nephrology

Perditer Okyere, Richard K D Ephraim, Isaac Okyere, Joseph Attakorah, Dorcas Serwaa, Grace Essuman, Albert Abaka-Yawson, Prince Adoba

Affiliations

  1. Department of Medicine, School of Medicine and Dentistry, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  2. Department of Medical Laboratory Science, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
  3. Renal Research Initiative , Cape Coast, Ghana.
  4. Department of Surgery, School of Medicine and Dentistry, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  5. Department of Pharmacy Practice, Faculty of Pharmacy, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  6. Department of Obstetrics and Gynecology, College of Medicine, Institute of Life and Earth Sciences, Pan African University, University of Ibadan, Ibadan, Nigeria.
  7. Department of Medical Laboratory Science, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana. [email protected].
  8. Renal Research Initiative , Cape Coast, Ghana. [email protected].
  9. Department of Medical Laboratory Science, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana.
  10. Trauma and Specialist Hospital, Ghana Health Service, Winneba, Ghana.

PMID: 33910506 PMCID: PMC8080413 DOI: 10.1186/s12882-021-02336-8

Abstract

BACKGROUND: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the commonest of the hereditary kidney diseases and mostly ensues in utero with signs delayed until after several decades. This study assessed the demographic, diagnostic (clinical and biochemical features) and therapeutic patterns among ADPKD patients who attended the nephrology unit of Komfo Anokye Teaching Hospital (KATH) from 2007 to 2018.

METHODS: This cross-sectional retrospective analysis of ADPKD patient records was conducted at the nephrology unit of KATH in October 2020. The records of 82 ADPKD was used for this study. Demographic, clinical, biochemical, ultrasonographic and therapeutic data was obtained, organized and analyzed with Statistical Package for the Social Sciences (SPSS).

RESULTS: ADPKD was most prevalent in people within the ages of 31-40 years (25.6 %), with a male (52.4 %) preponderance. The most common clinical features presented were flank pain (30.5 %) and bipedal swelling (18.3 %). Hypertension (42.7 %), urinary tract infections (UTIs) (19.5 %), and anemia (13.4 %) were the most common complications reported. Average level of HDL-c was higher in females (1.7) than in males (1.2) (p = 0.001). Hematuria (34 %) and proteinuria (66 %) were among the biochemical derangements presented. About 81.7 % had CKD at diagnosis with the majority in stages 1 (27.0 %), 3(23.2 %) and 5 (20.3 %). Poor corticomedullary differentiation was observed in 90.2 % of participants and increased echogenicity was observed in 89.0 % of the participants. Estimated GFR (eGFR) correlated positively with echotexture (r = 0.320, p = 0.005) and negatively with CMD (r= -0.303, p = 0.008). About 95.1 % of patients were on conservative therapy including: 73.2 %, 52.4 %, 22.0 %, 13.4 %, 8.5 % on Irebesartan/Lisinopril, Nifecard XL, Hydralazine, Methyldopa and Bisoprolol respectively for hypertension; 26.8 and 3.7 % on Gliclazide and Metformin respectively for Type 2 diabetes mellitus; 25.6 %, 24.4 and 18.3 % on CaCO

CONCLUSIONS: ADPKD occurs in people aged ≥ 31 years with a higher male preponderance. Clinical features include flank and abdominal pain, bipedal swelling, headache, amongst others. Uremia, hematuria, proteinuria, decreased eGFR, were the common biochemical derangements reported with higher severity detected in men. The therapeutic interventions mostly involved conservative therapy to manage symptoms and other comorbid conditions and rarely renal replacement therapy (RRT).

Keywords: Autosomal dominant polycystic kidney disease; Biochemical derangements; Chronic kidney disease; Clinical features; Demographic characteristics

References

  1. Am J Hypertens. 2004 Nov;17(11 Pt 1):1029-34 - PubMed
  2. Lancet. 2019 Mar 2;393(10174):919-935 - PubMed
  3. Adv Chronic Kidney Dis. 2010 Mar;17(2):115-7 - PubMed
  4. Can Urol Assoc J. 2014 Jul;8(7-8):278-82 - PubMed
  5. Expert Rev Mol Diagn. 2017 Oct;17(10):885-895 - PubMed
  6. N Engl J Med. 2010 Aug 26;363(9):820-9 - PubMed
  7. Int J Nephrol Renovasc Dis. 2018 Jan 31;11:41-51 - PubMed
  8. BMJ Case Rep. 2014 Jan 13;2014: - PubMed
  9. J Am Soc Nephrol. 1994 Dec;5(6):1349-54 - PubMed
  10. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):175-184 - PubMed
  11. Nephrol Dial Transplant. 2013 Jun;28(6):1472-87 - PubMed
  12. Braz J Med Biol Res. 2006 Apr;39(4):533-8 - PubMed
  13. Afr Health Sci. 2018 Sep;18(3):671-680 - PubMed
  14. Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1172-8 - PubMed
  15. Int J Nephrol. 2020 Apr 13;2020:8967258 - PubMed
  16. Dis Mon. 2020 May;66(5):100887 - PubMed
  17. N Engl J Med. 2008 Oct 2;359(14):1477-85 - PubMed
  18. BMC Emerg Med. 2018 Nov 1;18(1):38 - PubMed
  19. Am J Hum Genet. 2016 Jun 2;98(6):1193-1207 - PubMed
  20. Clin J Am Soc Nephrol. 2020 Jan 7;15(1):69-79 - PubMed
  21. PLoS One. 2018 Jan 16;13(1):e0190430 - PubMed
  22. Nephron Clin Pract. 2011;117(3):c270-5 - PubMed
  23. G Tec Nefrol Dial. 2017 Apr;29(2):80-84 - PubMed
  24. Kidney Int. 2004 Oct;66(4):1561-9 - PubMed
  25. Am J Kidney Dis. 2000 Jun;35(6):1072-5 - PubMed
  26. Nephrol Dial Transplant. 2001 Feb;16(2):410-1 - PubMed
  27. Am J Kidney Dis. 2016 May;67(5):792-810 - PubMed
  28. Nephrol Dial Transplant. 2013 Feb;28(2):380-5 - PubMed
  29. J Assoc Physicians India. 2020 Feb;68(2):76-79 - PubMed
  30. J Intern Med. 2011 Mar;269(3):289-98 - PubMed

Publication Types